Amit Kumar
Amit Kumar has made 3 open-market purchases worth $57k since Sep 28, 2026, in 1 company. The latest: $16k of ANIX, filed Nov 2, 2026, scored 32 out of 100.
CEO, Anixa Biosciences Inc
Follow Amit Kumar, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Nov 2 Form 4 (opens sec.gov) |
ANIXAnixa Biosciences Inc · CEOCEO · Near 52-week low | +1% stake | 32 | $16k 5,000 at $3.17 |
— | — |
| Oct 22 Form 4 (opens sec.gov) |
ANIXAnixa Biosciences Inc · CEOCEO · Near 52-week low | +1% stake | 32 | $22k 8,000 at $2.72 |
— | — |
| Sep 28 Form 4 (opens sec.gov) |
ANIXAnixa Biosciences Inc · CEOCEO · Near 52-week low | +1% stake | 32 | $19k 7,000 at $2.78 |
— | — |
Questions
What stock has Amit Kumar bought?
ANIX (Anixa Biosciences Inc), all on the open market and reported on SEC Form 4.
When did Amit Kumar last buy?
Nov 2, 2026: 5,000 shares of ANIX at $3.17, $16k in all (Form 4 (opens sec.gov)).
Has Amit Kumar filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Amit Kumar a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Nov 2, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer